DEUTSCHE BANK AG\ - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 130 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.56 and the average weighting 0.3%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,308,000
+92.6%
74,522
+6.4%
0.00%
Q2 2021$679,000
+977.8%
70,024
+1103.0%
0.00%
Q1 2021$63,000
-14.9%
5,821
+14.8%
0.00%
Q4 2020$74,000
-96.2%
5,072
-96.3%
0.00%
-100.0%
Q3 2020$1,956,000
+1327.7%
137,661
+714.6%
0.00%
Q2 2020$137,000
-98.6%
16,900
-99.3%
0.00%
-100.0%
Q1 2020$10,022,000
+501000.0%
2,480,576
+29083.2%
0.01%
Q2 2019$2,000
-75.0%
8,500
-30.9%
0.00%
Q1 2019$8,000
-99.2%
12,300
-92.8%
0.00%
Q3 2018$986,000
-32.7%
170,114
-30.3%
0.00%
Q2 2018$1,464,000
+902.7%
244,114
+1101.4%
0.00%
Q1 2018$146,000
-82.5%
20,319
-82.4%
0.00%
-100.0%
Q4 2017$835,000
+2683.3%
115,288
+1860.0%
0.00%
Q3 2017$30,000
-25.0%
5,882
-35.4%
0.00%
Q2 2017$40,000
-11.1%
9,100
+23.0%
0.00%
Q1 2017$45,000
+32.4%
7,400
+21.3%
0.00%
Q4 2016$34,000
-48.5%
6,100
+33.3%
0.00%
Q3 2016$66,000
+200.0%
4,577
+76.0%
0.00%
Q2 2016$22,000
-61.4%
2,600
-57.9%
0.00%
Q1 2016$57,000
-13.6%
6,178
+17.1%
0.00%
Q4 2015$66,000
-60.0%
5,274
-30.6%
0.00%
Q2 2015$165,000
+27.9%
7,600
+18.8%
0.00%
Q1 2015$129,0006,4000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders